Literature DB >> 27711167

Correction: Endoscopic Gold Fiducial Marker Placement into the Bladder Wall to Optimize Radiotherapy Targeting for Bladder-Preserving Management of Muscle-Invasive Bladder Cancer: Feasibility and Initial Outcomes.

Maurice M Garcia, Alexander R Gottschalk, Jonathan Brajtbord, Badrinath R Konety, Maxwell V Meng, Mack Roach, Peter R Carroll.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0089754.].

Entities:  

Year:  2016        PMID: 27711167      PMCID: PMC5053526          DOI: 10.1371/journal.pone.0164558

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


There is an error regarding the consent procedure reported within the Ethics Statement of the Materials and Methods section. The written informed consent obtained was for clinical treatment with markers, and not part of a prospective research study as is suggested by the statement. The Ethics Statement should read: Approval for this study was obtained from our institution's (University of California San Francisco) Committee for Human Research. Written informed consent was only obtained for clinical treatment with the study’s markers.
  1 in total

1.  Endoscopic gold fiducial marker placement into the bladder wall to optimize radiotherapy targeting for bladder-preserving management of muscle-invasive bladder cancer: feasibility and initial outcomes.

Authors:  Maurice M Garcia; Alexander R Gottschalk; Jonathan Brajtbord; Badrinath R Konety; Maxwell V Meng; Mack Roach; Peter R Carroll
Journal:  PLoS One       Date:  2014-03-03       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.